三瀬 節子

Medicine & Life Sciences

1. T-Lymphocytes 100%
2. OP3-4 peptide 87%
3. Osteogenesis 63%
4. Immune Tolerance 48%
5. Bone Regeneration 43%
6. Regulatory T-Lymphocytes 41%
7. Peptides 40%
8. Macrophages 38%
9. RNA Interference 36%
10. Interleukin-23 34%
11. Cytokines 34%
12. Osteoblasts 32%
13. Interleukin-23 Subunit p19 31%
14. Desmoglein 3 30%
15. Experimental Arthritis 29%
16. Bone and Bones 28%
17. Inbred DBA Mouse 28%
18. Stem Cells 28%
19. recombinant human bone morphogenetic protein-2 27%
20. staphylococcal enterotoxin B 27%
21. Adoptive Immunotherapy 27%
22. Peripheral Tolerance 26%
23. Immunity 26%
24. Leishmania major 25%
25. Alveolar Bone Loss 25%
26. T-Cell Antigen Receptor 25%
27. Thymus Gland 25%
28. Microfilament Proteins 25%
29. Severe Acute Respiratory Syndrome 24%
30. Organelle Biogenesis 24%
31. Bone Morphogenetic Protein 2 24%
32. Pemphigus 24%
33. Coronavirus 24%
34. Mechanistic Target of Rapamycin Complex 1 24%
35. Dendritic Cells 23%
36. Immunotherapy 23%
37. Tooth Extraction 23%
38. Pseudopodia 23%
39. Collagen Type II 22%
40. Arthritis 22%
41. Janus Kinases 21%
42. Anura 20%
43. Suppressor of Cytokine Signaling Proteins 20%
44. Maxilla 20%
45. Stem Cell Transplantation 20%
46. Small Interfering RNA 20%
47. Ovum 19%
48. Endocytosis 19%
49. Hematopoietic Stem Cells 19%
50. Nitric Oxide Synthase 18%